Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2016-08-11

FDA Approved: SILVER SULFADIAZINE — Supplemental Application (Ascend Laboratories, LLC)

View source ↗

Summary

The FDA approved a supplemental application for Silver sulfadiazine by Ascend Laboratories, resulting in changes to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Silver sulfadiazine (silver sulfadiazine)

Snippet

SUPPL AP for SILVER SULFADIAZINE (SILVER SULFADIAZINE)